BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17341579)

  • 1. Diabetes and the risk of osteonecrosis of the jaw.
    Favus MJ
    J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates and osteonecrosis of the jaw.
    Shenker NG; Jawad AS
    Rheumatology (Oxford); 2007 Jul; 46(7):1049-51. PubMed ID: 17500074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 9. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY; Geist JR; Aksu M
    J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
    Jimenez-Soriano Y; Bagan JV
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteoporosis, fracture risk, and prosthodontic implications.
    Koka S; Salinas TJ; Kennel KA
    Int J Prosthodont; 2009; 22(5):505-6. PubMed ID: 20095203
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
    Fleisher KE; Glickman RS
    J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
    Carlson ER
    Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmenopausal females and the link between oral bisphosphonates and osteonecrosis of the jaw: a clinical review.
    Haumschild MS; Haumschild RJ
    J Am Acad Nurse Pract; 2010 Oct; 22(10):534-9. PubMed ID: 21040087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J; Mahia IV; Meizoso MO; Vazquez T
    Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN; Dojcinovic I; Richter M; Hugentobler M
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.